Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Globe Newswire•12/08/2026•08:00 ET
0
Whiz Insights
Completed enrollment of MIST global Phase 2b trial of AP01 with 398 patients; topline data expected in the second half of 2027
Two abstracts accepted for presentation at the European Respiratory Society (ERS) Congress, including data modeling AP01 lung tissue distribution
Get started
Create a free account to read the full story.